227 related articles for article (PubMed ID: 33567514)
1. Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die.
Wong MM; Joyson SM; Hermeking H; Chiu SK
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567514
[TBL] [Abstract][Full Text] [Related]
2. AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p.
Chou J; Kaller M; Jaeckel S; Rokavec M; Hermeking H
Mol Cancer; 2022 May; 21(1):120. PubMed ID: 35624466
[TBL] [Abstract][Full Text] [Related]
3. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
Jackstadt R; Röh S; Neumann J; Jung P; Hoffmann R; Horst D; Berens C; Bornkamm GW; Kirchner T; Menssen A; Hermeking H
J Exp Med; 2013 Jul; 210(7):1331-50. PubMed ID: 23752226
[TBL] [Abstract][Full Text] [Related]
4. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
5. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
6. c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53.
Kaller M; Shi W; Hermeking H
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831504
[TBL] [Abstract][Full Text] [Related]
7. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.
Chen S; Chiu SK
Mol Cell Biochem; 2015 Sep; 407(1-2):57-68. PubMed ID: 26037074
[TBL] [Abstract][Full Text] [Related]
8. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
9. Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells.
Wang Y; Cheng X; Samma MK; Kung SKP; Lee CM; Chiu SK
Mol Cell Biochem; 2018 Jun; 443(1-2):193-204. PubMed ID: 29188535
[TBL] [Abstract][Full Text] [Related]
10. TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.
Hou Z; Guo K; Sun X; Hu F; Chen Q; Luo X; Wang G; Hu J; Sun L
Mol Cancer; 2018 Dec; 17(1):172. PubMed ID: 30541550
[TBL] [Abstract][Full Text] [Related]
11. Ectopic AP4 expression induces cellular senescence via activation of p53 in long-term confluent retinal pigment epithelial cells.
Wang Y; Wong MM; Zhang X; Chiu SK
Exp Cell Res; 2015 Nov; 339(1):135-46. PubMed ID: 26439195
[TBL] [Abstract][Full Text] [Related]
12. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms.
Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS
Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731
[TBL] [Abstract][Full Text] [Related]
13. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating
Wang L; Meng Y; Xu JJ; Zhang QY
Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
15. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
16. AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.
Chen C; Cai Q; He W; Lam TB; Lin J; Zhao Y; Chen X; Gu P; Huang H; Xue M; Liu H; Su F; Huang J; Zheng J; Lin T
Cell Death Dis; 2017 Oct; 8(10):e3060. PubMed ID: 28981098
[TBL] [Abstract][Full Text] [Related]
17. The c-MYC-AP4-p21 cascade.
Jung P; Hermeking H
Cell Cycle; 2009 Apr; 8(7):982-9. PubMed ID: 19270520
[TBL] [Abstract][Full Text] [Related]
18. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
19. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the prognostic value and functional roles of transcription factor AP4 in colorectal cancer.
Yang J; Ma JP; Xiao S; Zhang XH; Xu JB; Chen CQ; Cai SR; He YL
Oncol Lett; 2018 May; 15(5):7545-7554. PubMed ID: 29725460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
